CYDY - CytoDyn (CYDY) inks leronlimab supply deal in Brazil

CytoDyn (CYDY) has executed an exclusive supply and distribution agreement with Biomm S.A. in Brazil, enabling Biomm to sell leronlimab in the region following regulatory clearance. CYDY has committed to conduct clinical trials in Brazil for all current indications for leronlimab (i.e., Long-Hauler COVID-19, NASH and cancer).Also recently, the company provided an update on leronlimab-treated COVID-19 patient.Patient in Philippines improved significantly 35 hours after first injection of leronlimab and was released 3 days later.

For further details see:

CytoDyn (CYDY) inks leronlimab supply deal in Brazil